Novartis
4 stories
-
healthWHO Approves First Malaria Drug for Newborns, Addressing Critical Healthcare Gap
The World Health Organization has prequalified the first malaria treatment specifically designed for newborns and infants, marking a significant step in combating the disease in vulnerable populations.
-
healthFDA Cracks Down on Biologics Marketing Over Misleading Claims
The FDA issues untitled letters to four major pharma firms for promoting unapproved survival outcomes in biologic therapies, signaling a sharp uptick in enforcement.
-
healthSecukinumab Shows Long-Term Bone Protection in Psoriatic Arthritis
New 48-month data confirm secukinumab preserves bone structure and controls disease activity in psoriatic arthritis patients.
-
healthSix Critical Numbers Every Woman Must Know for Heart Health
Cardiovascular disease is the leading cause of death among U.S. women. These six clinical metrics-blood pressure, LDL, HDL, triglycerides, total cholesterol, and Lp(a)-define individual cardiac risk.